Neurotoxic effects of gadopentetate dimeglumine: Behavioral disturbance and morphology after intracerebroventricular injection in rats

American Journal of Neuroradiology

Volumn 17, Issue 2, 1996, Pages 365-373

  Ray, D E ^a   Cavanagh, J B ^a   Nolan, C C ^a   Williams, S C R ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Animal studies; Contrast media, paramagnetic; Contrast media, toxicity

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; SUCROSE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATAXIA; BRAIN INJURY; CENTRAL PONTINE MYELINOLYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; HISTOLOGY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MYOCLONUS; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; STEREOTYPY; TREMOR;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN STEM; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; GADOLINIUM DTPA; INJECTIONS, INTRAVENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MOTOR ACTIVITY; MOTOR SKILLS; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; RATS; RATS, INBRED F344; SPINAL CORD;

EID: 0030042252     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Graca JG, Davison FC, Feavel JB. Comparative toxicity of stable rare earth compounds, II: effect of citrate and EDTAate on acute toxicity in mice and guinea pigs. Arch Environ Health 1962;5: 437-444
2. Graca JG, Davison FC, Feavel JB. Comparative toxicity of stable rare earth compounds, III: acute toxicity of intravenous injections of chlorides and chelates in dogs. Arch Environ Health 1964;8. 555-564
3. Goldstein HA, Kashanian FK, Blumetti RF, Holyoak WL, Hugo FP, Blumenfield DM. Safety assessment of gadopentetate dimeglumine in U.S. clinical trials. Radiology 1990;174:17-23
4. Harbury OL. Generalized seizure after IV administration of gadopentetate dimeglumine. AJNR Am J Neuroradiol 1991,12:666
5. Smith ME, Stone LA, Albert PS, et al. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol 1993;33:480-489
6. Weinmann H-J, Brasch RC, Press W, Wesbey GE. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR Am J Roentgenol 1984;142:619-624
7. Roman-Goldstein SM, Barnett PA, McCormick CI, Ball MJ, Ramsey F, Neuwelt EA. Effects of gadopentetate dimeglumine administration after osmotic blood-brain barrier disruption: toxicity and MR imaging findings. AJNR Am J Neuroradiol 1991;12:885-890
8. Salahuddin TS, Johansson BB, Kalimo H, Olsson Y. Structural changes in the rat brain after carotid infusions of hyperosmolar solutions: a light microscopic and immunohistochemical study. Neuropathol Appl Neurobiol 1988;14:467-482
9. Morris TW, Ekholm SE, Prentice LJ. The effects of gadoliniumDTPA and -DOTA on neural tissue metabolism. Invest Radiol 1991;26:1087-1090
10. Federal Health Office. Arzneitmittel-schnellinformattonen: Ondanseteron und gadopentetat. Pharm Zeitung 1993;138:65
11. Goodrich CA, Greehey B, Miller TB, Pappenheimer JR. Cerebral ventricular infusions in unrestrained rats. J Appl Physiol 1969;26: 137-140
12. Brown AW, Brierley JB. The nature, distribution and earliest stages of anoxic-ischaemic nerve cell damage in the rat brain as defined by the optical microscope. Br J Exp Pathol 1968;49:87-106
13. Junck L, Marshall WH. Meurotoxicity of radiological contrast agents. Ann Neurol 1983;13:469-484
14. Adams MD, Barco SJ, Galen KP, Hynes MR, Ralston WH. Motor coordination testing of the neurotoxicity of paramagnetic chelates. In: Rinck PA, Müller RN, eds. New Developments in Contrast Agents: Proceedings of the 3rd special topic seminar of the European Magnetic Resonance Forum. Hamburg: European Magnetic Resonance Forum Foundation, 1993:51-58
15. Di Chiro G, Knopp RH, Girton ME. MR cisternography and myelography with Gd-DTPA in monkeys. Radiology 1985;157:373-377
16. Gregorios JB, Gregorios AB, Mora J, Marcillo A, Fojaco RM, Green B. Morphologic alterations in rat brain following systemic and intraventricular methotrexate injection: light and electron microscopic studies. J Neuropathol Exp Neurol 1989;48:33-47
17. Yajima K, Suzuki K. Ultrastructural changes of oligodendroglia and myelin sheaths induced by ethidium bromide. Neuropathol Exp Neurobiol 1979;5:47-62
18. Neuwelt EA, Pagel M, Barnett P, Glassberg M, Frenkel EP. Pharmacology and toxicity of intracarotid adriamycin administration following osmotic blood-brain barrier modification. Cancer Res 1981;41:4466-4470
19. DeMatteis F, Ray DE. Studies on cerebellar haem metabolism in the rat in vivo. J Neurochem 1982;39:551-556
20. Adams RD, Victor M Mancall EL. Central pontine myelinolysis, a hitherto undescribed disease occurring in alcoholic and malnourished patients. Arch Neurol Psychiatry 1959;81:154-172
21. McKee AC, Winkelman MD, Banker BQ. Central pontine myelinolysis in severely burned patients: relationship to serum osmolarity. Neurology 1988;38:1211-1217
22. Kleinschmidt-DeMasters BK, Norenberg MD. Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis. Science 1981;211:1068-1070
23. Kleinschmidt-DeMasters BK, Nordberg MD. Neuropathologic observations in electrolyte-induced myelinolysis in the rat. J Neuro pathol Exp Neurol 1982;41:67-80
24. Ayus JC, Krothapalli RK, Armstrong DA. Rapid correction of severe hyponatremia in the rat: histopathological changes in the brain. Am J Physiol 1985;248:F711-F719
25. Laureno R. Central pontine myelinolysis following rapid correction of hyponatremia. Ann Neurol 1983;13:232-242
26. Illowsky BP, Laureno R. Encephalopathy and myelinolysis after rapid correction of hyponatraemia. Brain 1987;110:855-867
27. Zwick D, Friede RL, Roessmann U. Central spinal myelinolysis. Neurology 1985;35:891-893
28. Tweedle MF. Physicochemical properties of gadoteridol and other magnetic resonance contrast agents. Invest Radiol 1992;27(suppl 1):S2-S6
29. Cacheris WP, Quay SC, Rocklage SM. The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn Reson Imaging 1990;8:467-481
30. Szerdahelyi P, Käsa P. Partial depletion and altered distribution of synaptic zinc in the rat hippocampus after treatment with sodium diethyldithiocarbamate. Brain Res 1987;422:287-294
31. Wolf G, Schmidt W. Zinc and glutamate dehydrogenase in putative glutamatergic brain structures. Acta Biochem 1983;72:15-23
32. Pérez-Clausell J, Frederickson CJ, Danscher G. Amygdaloid efferents through the stria terminalis in the rat give origin to zinccontaining boutons. J Comp Neurol 1989;290:201-212
33. Komoly S, Jeyasingham MD, Pratt OE, Lantos PL. Decrease in oligodendrocyte carbonic anhydrase activity preceding myelin degeneration in cuprizone induced demyelination. J Neurol Sci 1987;79:141-148
34. Carlton WW Spongiform encephalopathy induced in rats and guinea pigs by cuprizone. Exp Mol. Pathol 1959;10:274-287
35. Kesterson JW, Carlton WW. Histopathologic and enzyme histochemical observations of the cuprizone-induced brain edema. Exp Mol Pathol 1971;15:82-96